Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $32

Benzinga · 3d ago
Barclays analyst Glen Santangelo maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $30 to $32.